Human pancreatic duct cell-derived iPSCs show enhanced differentiation into insulin-producing cells
Cell Transplantation · 2026-07 · 35
DOI: 10.1177/09636897261469970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, online erschienen am 18.07.2026. Verfasst von Sung-Bin Lim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cell Differentiation, Pancreatic Ducts, Insulin-Secreting Cells. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute.
Abstract (Originalsprache)
Islet transplantation is a promising treatment for diabetes, but the shortage of donor islets limits its broad application. Induced pluripotent stem cells (iPSCs) provide an alternative source for generating insulin-producing cells; however, whether the somatic cell origin of human iPSCs influences pancreatic endocrine differentiation remains incompletely defined. In this study, we generated iPSCs from human pancreatic duct cells (HD-iPSCs) and compared their differentiation propensity and functional characteristics with human fibroblast-derived iPSCs (HF-iPSCs) under identical differentiation conditions. HD-iPSC-derived cells showed higher expression of pancreatic endocrine and β-cell-associated markers, including insulin, PDX1, and FOXA2, compared with HF-iPSC-derived cells. Flow cytometric analysis further confirmed a higher proportion of insulin-positive cells in differentiated HD-iPSC-derived cells. Functionally, HD-iPSC-derived cells exhibited greater glucose-stimulated C-peptide secretion than HF-iPSC-derived cells, although their secretory capacity remained lower than that of native human islets. Following transplantation into streptozotocin-induced diabetic mice, HD-iPSC-derived cells reduced blood glucose levels more effectively than HF-iPSC-derived cells, and insulin-positive grafts were detected in vivo. These findings suggest that human pancreatic duct cell-derived iPSCs have enhanced pancreatic endocrine differentiation potential compared with fibroblast-derived iPSCs. Although further maturation and optimization are required, pancreatic duct cells may represent a favorable somatic cell source for generating iPSC-derived insulin-producing cells for diabetes cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Gyeonggi-do, Korea.
ORCID-Profile: Moon-Kyu Lee
Förderung
- Korea Health Industry Development Institute
Zitieren
APA
Lim, S. B., & Lee, M. K. (2026). Human pancreatic duct cell-derived iPSCs show enhanced differentiation into insulin-producing cells. Cell Transplantation, 35. https://doi.org/10.1177/09636897261469970
Vancouver
Lim SB, Lee MK. Human pancreatic duct cell-derived iPSCs show enhanced differentiation into insulin-producing cells. Cell Transplantation. 2026;35. doi:10.1177/09636897261469970
BibTeX
@article{Lim2026,
author = {Lim, Sung-Bin and Lee, Moon-Kyu},
title = {Human pancreatic duct cell-derived iPSCs show enhanced differentiation into insulin-producing cells},
journal = {Cell Transplantation},
year = {2026},
volume = {35},
doi = {10.1177/09636897261469970}
}
EUVIMED